Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Breast Cancer
•
Radiation Oncology
Would you use bolus in patients s/p mastectomy and reconstruction if they had dermal involvement?
Answer from: Radiation Oncologist at Community Practice
Pathological dermis involvement is a risk factor of LR and I would use bolus for this situation.
Sign in or Register to read more
Answer from: Radiation Oncologist at Academic Institution
While we are increasingly omitting bolus, dermal involvement would concern me and I would use bolus.
Comments
Radiation Oncologist at University of Miami/Jackson Memorial Medical Center
Drs. @Sushil Beriwal and @Chirag S. Shah, would yo...
Radiation Oncologist at Cleveland Clinic
I typically start with 1st 13 fractions and will m...
9600
9602
Sign in or Register to read more
11755
11772
Related Questions
For a patient receiving postmastectomy IMRT to chest wall with expander and regional nodes including IMN, what constraint would you use for dose to the contralateral chest wall/implant if the patient also had a mastectomy and reconstruction on that side?
Would you do APBI for encapsulated papillary carcinoma with negative margins and no surgical axillary assessment?
What are your top takeaways from SABCS 2023?
Is there a role for radiation therapy for florid LCIS managed with lumpectomy?
In light of the NSABP B51 data presented at SABCS, will you defer RNI in all patients with negative nodes after chemotherapy?
What radiation would you offer for isolated nodal recurrence in a patient who received APBI for breast cancer about 2 years ago after ALND?
Would you offer reirradiation for a patient who had prior MammoSite PBI?
Is a completion axillary dissection required for a patient with clinical N+ disease who had a complete clinical response in the axilla to neoadjuvant systemic therapy but is found to ypN+ disease on sentinel node biopsy?
Is it time to re-evaluate the timing of radiation and chemotherapy with the adoption of hypofractionated courses of radiation for breast cancer?
Would you offer breast conserving therapy in a patient with breast cancer and Buerger's disease of the breast?